92 related articles for article (PubMed ID: 25850444)
1. A novel NGR-conjugated peptide targets DNA damage responses for radiosensitization.
Ma J; Zhang D; Ying X; Zhao Y; He C; Zhu Q; Han S
Curr Cancer Drug Targets; 2015; 15(6):533-41. PubMed ID: 25850444
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
Cariveau MJ; Tang X; Cui XL; Xu B
Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo.
Yu W; Gu K; Yu Z; Yuan D; He M; Ma N; Lai S; Zhao J; Ren Z; Zhang X; Shao C; Jiang GL
Cancer Lett; 2013 Feb; 329(1):109-17. PubMed ID: 23142289
[TBL] [Abstract][Full Text] [Related]
4. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
[TBL] [Abstract][Full Text] [Related]
5. Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation.
Yu JI; Choi C; Shin SW; Son A; Lee GH; Kim SY; Park HC
Sci Rep; 2017 Nov; 7(1):14986. PubMed ID: 29118323
[TBL] [Abstract][Full Text] [Related]
6. Modification of cyclic NGR tumor neovasculature-homing motif sequence to human plasminogen kringle 5 improves inhibition of tumor growth.
Jiang W; Jin G; Ma D; Wang F; Fu T; Chen X; Chen X; Jia K; Marikar FM; Hua Z
PLoS One; 2012; 7(5):e37132. PubMed ID: 22590653
[TBL] [Abstract][Full Text] [Related]
7. The Biofunctional Effects of Mesima as a Radiosensitizer for Hepatocellular Carcinoma.
Jeong YK; Oh JY; Yoo JK; Lim SH; Kim EH
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013255
[TBL] [Abstract][Full Text] [Related]
8. An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.
Zheng YB; Shang BY; Li Y; Zhen YS
Biomed Pharmacother; 2013 Mar; 67(2):164-71. PubMed ID: 23206754
[TBL] [Abstract][Full Text] [Related]
9. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.
Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC
J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950
[TBL] [Abstract][Full Text] [Related]
10. [Cytotoxicity of pentoxifylline and its effect on human hepatoma cell line Hep3b radiosensitivity].
Wu DH; Liu L; Chen LH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):305-7. PubMed ID: 16546733
[TBL] [Abstract][Full Text] [Related]
11. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.
Kim EH; Kim MS; Furusawa Y; Uzawa A; Han S; Jung WG; Sai S
Oncotarget; 2016 Dec; 7(49):80568-80578. PubMed ID: 27802188
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.
Dai XF; Ding J; Zhang RG; Ren JH; Ma CM; Wu G
Int J Radiat Biol; 2013 Sep; 89(9):724-31. PubMed ID: 23682582
[TBL] [Abstract][Full Text] [Related]
13. RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo.
Wang X; Qiao X; Shang Y; Zhang S; Li Y; He H; Chen SZ
Amino Acids; 2017 May; 49(5):931-941. PubMed ID: 28236246
[TBL] [Abstract][Full Text] [Related]
14. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.
Buckel L; Savariar EN; Crisp JL; Jones KA; Hicks AM; Scanderbeg DJ; Nguyen QT; Sicklick JK; Lowy AM; Tsien RY; Advani SJ
Cancer Res; 2015 Apr; 75(7):1376-1387. PubMed ID: 25681274
[TBL] [Abstract][Full Text] [Related]
15. Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress.
Cuneo KC; Morgan MA; Davis MA; Parcels LA; Parcels J; Karnak D; Ryan C; Liu N; Maybaum J; Lawrence TS
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):782-90. PubMed ID: 26975930
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of (-)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge
Choi C; Cho Y; Son A; Shin SW; Lee YJ; Park HC
Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 33003597
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SENP6-induced radiosensitization of human hepatocellular carcinoma cells by blocking radiation-induced NF-κB activation.
Qian J; Luo Y; Gu X; Wang X
Cancer Biother Radiopharm; 2013 Apr; 28(3):196-200. PubMed ID: 23461386
[TBL] [Abstract][Full Text] [Related]
18. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor efficacy and pre-clinical immunogenicity of IFNα2a-NGR.
Zhang B; Gao B; Dong S; Zhang Y; Wu Y
Regul Toxicol Pharmacol; 2011 Jun; 60(1):73-8. PubMed ID: 21338646
[TBL] [Abstract][Full Text] [Related]
20. Clofarabine acts as radiosensitizer in vitro and in vivo by interfering with DNA damage response.
Cariveau MJ; Stackhouse M; Cui XL; Tiwari K; Waud W; Secrist JA; Xu B
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):213-20. PubMed ID: 18037589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]